Nkarta (NKTX) Accumulated Depreciation & Amortization (2019 - 2026)

Nkarta's quarterly Accumulated Depreciation & Amortization came in at $2.3 million in Q1 2026, little changed year-on-year from $2.3 million in Q1 2025, and down 75.0% quarter-over-quarter from $9.2 million in Q4 2025.

Nkarta has reported Accumulated Depreciation & Amortization for 8 years, with the latest figure at $2.3 million in Q1 2026.

  • For the quarter ending Q1 2026, Accumulated Depreciation & Amortization changed 0.0% year-over-year to $2.3 million; the trailing twelve-month figure through Mar 2026 stood at $2.3 million (changed 0.0% YoY), and the FY2025 full-year result was $9.2 million, changed 0.0% from the prior year.
  • Accumulated Depreciation & Amortization for Q1 2026 stood at $2.3 million, down from $9.2 million in the prior quarter.
  • The five-year high for Accumulated Depreciation & Amortization was $9.2 million in Q4 2024, with the low at $600000.0 in Q1 2022.
  • Average Accumulated Depreciation & Amortization over 5 years is $3.0 million, with a median of $2.3 million recorded in 2024.
  • Year-over-year, Accumulated Depreciation & Amortization sank 33.33% in 2023 and soared 187.5% in 2024.
  • Tracing NKTX's Accumulated Depreciation & Amortization over 5 years: stood at $2.6 million in 2022, then soared by 126.92% to $5.9 million in 2023, then soared by 55.93% to $9.2 million in 2024, then changed by 0.0% to $9.2 million in 2025, then slumped by 75.0% to $2.3 million in 2026.
  • The last three Accumulated Depreciation & Amortization figures came in at $2.3 million (Q1 2026), $9.2 million (Q4 2025), and $2.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Nkarta 232.80 Mn 232.80 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 2.30 Mn
Mar 31, 2026 2.30 Mn
Dec 31, 2025 9.20 Mn
Dec 31, 2025 9.20 Mn
Sep 30, 2025 2.30 Mn
Sep 30, 2025 2.30 Mn
Jun 30, 2025 4.60 Mn
Jun 30, 2025 4.60 Mn
Mar 31, 2025 2.30 Mn
Mar 31, 2025 2.30 Mn
Dec 31, 2024 9.20 Mn
Dec 31, 2024 9.20 Mn
Sep 30, 2024 2.40 Mn
Sep 30, 2024 2.40 Mn
Jun 30, 2024 2.30 Mn
Jun 30, 2024 2.30 Mn
Mar 31, 2024 2.30 Mn
Mar 31, 2024 2.30 Mn
Dec 31, 2023 5.90 Mn
Dec 31, 2023 5.90 Mn
Sep 30, 2023 2.00 Mn
Sep 30, 2023 2.00 Mn
Jun 30, 2023 800,000.00
Jun 30, 2023 800,000.00
Mar 31, 2023 800,000.00
Mar 31, 2023 800,000.00
Dec 31, 2022 2.60 Mn
Dec 31, 2022 2.60 Mn
Sep 30, 2022 700,000.00
Sep 30, 2022 700,000.00
Jun 30, 2022 1.20 Mn
Jun 30, 2022 1.20 Mn
Mar 31, 2022 600,000.00
Mar 31, 2022 600,000.00
Dec 31, 2021 1.80 Mn
Dec 31, 2021 1.80 Mn
Sep 30, 2021 500,000.00
Sep 30, 2021 500,000.00
Jun 30, 2021 700,000.00
Jun 30, 2021 700,000.00
Mar 31, 2021 300,000.00
Mar 31, 2021 300,000.00
Dec 31, 2020 800,000.00
Dec 31, 2020 800,000.00
Sep 30, 2020 500,000.00
Sep 30, 2020 500,000.00
Jun 30, 2020 100,000.00
Jun 30, 2020 100,000.00
Mar 31, 2020 100,000.00
Mar 31, 2020 100,000.00
Dec 31, 2019 400,000.00
Dec 31, 2019 400,000.00
Sep 30, 2019 300,000.00
Sep 30, 2019 300,000.00
Jun 30, 2019 300,000.00
Jun 30, 2019 300,000.00